India's leading hospital chain Apollo Hospitals reported robust financial results for the fourth quarter and full fiscal year 2026. According to reports from The Economic Times, the company announced an 18% year-on-year increase in consolidated revenue to ₹6,605 crores for Q4 FY26, while consolidated net profit grew 36% to ₹529 crores. The strong quarterly performance was driven by growth across core businesses including Healthcare Services, Diagnostics and Retail Health, and Digital and Pharmacy segments. The improvement in profitability was underpinned by strong operating leverage, higher realisations from complex care, and improving margins across digital and pharmacy businesses, offsetting continued investments in new capacities and digital scale-up.
For the full fiscal year 2026, Apollo Hospitals reported 16% year-on-year increase in consolidated revenue to ₹25,229 crores, while consolidated net profit grew 34% to ₹1,942 crore. As reported by The Economic Times, the robust performance was fueled by growth across its core businesses including Healthcare Services, Diagnostics and Retail Health, and Digital and Pharmacy segments. The company's consolidated EBITDA margins for the year improved to about 14.9 percent, with gains across segments despite continued investments in Apollo 24/7 and new hospital capacities.
According to The Economic Times, Apollo Hospitals achieved healthcare services revenue of ₹12,555 crores for FY26, up 16% year-on-year, with EBITDA margins at 24.4%. The company's occupancy rate improved to 68% in Q4 FY26 versus 67% in the same period in the previous year. Average revenue per occupied bed (ARPOB) rose 9% year-on-year to ₹1,87,208, while inpatient volumes grew 7% and average length of stay (ALOS) declined modestly to 3.19 days, signalling operational efficiencies and faster patient turnaround. As of March 31, Apollo Hospitals operated 8,131 beds across the network (excluding AHLL and managed beds).
The company's newer growth engines delivered strong results, with Apollo HealthCo (digital and pharmacy) revenue reaching ₹10,808 crore with sharp improvement in margins and profitability as scale benefits kicked in. The health and lifestyle segment (diagnostics and clinics) turned profitable at the bottom line in the quarter, further boosting consolidated earnings. Apollo HealthCo delivered its first full year of profitability, highlighting improving economics in the omnichannel pharmacy and digital health model. Health & Lifestyle (AHLL) grew 20% with margins expanding to 11.4%, aided by diagnostics growth and operational efficiencies.
As reported by The Economic Times, Apollo Hospitals aims to add another 1,500 operating beds in the next 12-18 months across key metros including Hyderabad and Kolkata, taking total operating beds to 10,000. The company operationalised four new hospitals in FY26 and several more are under development. Group Chief Financial Officer Krishnan Akhileswaran noted that growth during the quarter was supported by improved performance in CONGO-T specialties and growth in high-complexity procedures including lung and heart surgeries. The year marked a turning point for Apollo's digital strategy, with strategic moves including the combination of its maternity business with Cloudnine and the planned demerger and potential listing of its pharmacy and digital business by FY27.
